The Netherlands Journal of Medicine

Misdiagnosed polycythemia vera due to auto-phlebotomy.
pp. 2-2(1)
Authors: Creemers M.C.W.; Dofferhoff A.S.M.

A young Turkish woman with an infarctive sickle-cell-like crisis complicated by bone marrow necrosis, associated with serologically documented parvovirus B19 infection and double heterozygosity for hemoglobins S and E.
pp. 2-2(1)
Authors: Eichhorn R.; Buurke E.J.; Blok P.; Berends M.J.H.; Jansen C.L.

Proliferative and apoptotic indices in primary intestinal non-Hodgkin's lymphoma.
pp. 2-2(1)
Authors: Gisbertz I.A.M.; Schouten H.C.; Bot F.J.; Arends J.W.

Massive hematuria in sickle cell trait.
pp. 2-3(2)
Authors: van Henten M.J.; de la Fuente R.B.; Vasmel W.L.E.

Erythropoiesis in patients with advanced breast cancer on hormonal treatment.
pp. 3-3(1)
Authors: van Iperen C.E.; Rodenburg C.J.; Kraayenhagen R.J.; Rooda S.J.E.; Nortier J.W.R.; van de Wiel A.

The effect of Vorozole on breast cancer tissue aromatase activity and estrogen concentrations.
pp. 3-3(1)
Authors: de Jong P.C.; vd Ven J.; Nortier J.W.R.; Maitimu-Smeele I.; Donker G.H.; Thijssen J.H.H.; Slee P.H.T.J.; Blankenstein M.A.

Effect of low-dose oral etoposide on CA-125 in patients with advanced epithelial ovarian cancer.
pp. 3-4(2)
Authors: de Jong R.S.; Hofstra L.S.; Willemse P.H.B.; de Bruijn H.W.A.; de Vries E.G.E.; Boonstra H.; Mulder N.H.

Thyroid carcinoma in familial adenomatous polyposis in the Netherlands.
pp. 4-4(1)
Authors: van der Linde K.; Vasen H.F.A.; van Vliet A.C.M.

A patient with a primary myeloproliferative syndrome and an unique t(3;12)(q26;p13) associated with abnormal megakaryopoiesis
pp. 4-4(1)
Authors: van de Loosdrecht A.A.; van den Berg E.; van Imhoff G.W.

CD34 cell selection with high gradient magnetic cell sorting and transplantation in patients with breast cancer
pp. 4-5(2)
Authors: Roerdink H.T.J.; Schaafsma M.R.; Olthuis F.; Schenkeveld C.; Richel D.J.

Complete remission with 'quintuple therapy' of post-transplantation lymphoproliferative disorder (PTLD) in a liver transplant recipient.
pp. 5-5(1)
Authors: Schaar C.G.; van Hoek B.; van Krieken J.H.J.H.; Lamers C.B.H.W.

Treatment of intermediate and high-grade non-Hodgkin's lymphoma in the elderly.
pp. 5-5(1)
Authors: Peters F.P.J.; Lalisang R.I.; Erdkamp F.L.G.; Bron H.; Fickers M.; Schouten H.C.

Results from a population-based registry on paraproteinaemia and multiple myeloma (MM) conducted in the region of the Comprehensive Cancer Centre West (CCCW).
pp. 5-6(2)
Authors: Schaar C.G.; Ong F.; Snijder S.; Hermans J.; Noordijk E.M.; Weijermans P.W.; Gerrits W.B.J.; Seelen P.J.; Kluin P.M.; Franck P.F.H.; Kruijff H.; Kluin-Nelemans J.C.

Incidence of deep-vein thrombosis and pulmonary embolism during hospitalisation in a department of internal medicine.
pp. 6-6(1)
Authors: Schuurman B.; Den Heijer M.; Nijs A.M.; Graafsma S.J.

Acquired C1-inhibitor deficiency with IgA-kappa neutralizing antibody.
pp. 6-7(2)
Authors: van Spronsen D.J.; Hoorntje S.J.; Hannema A.J.; Hack C.E.

High prevalence of penicillin-resistant viridans streptococci in patients selected for intensive chemotherapy.
pp. 7-7(1)
Authors: Visser O.; Richel D.J.; Schaafsma M.R.; Hendrix M.G.R.

The development of inhibitory antibodies against factor VIII in a patient with moderate hemophilia A.
pp. 7-7(1)
Authors: Vlot A.J.; Wittebol S.

Factor VIIa is elevated by factor V Leiden.
pp. 7-8(2)
Authors: Waale W.; van Oerle R.; van Pampus L.; Lindhout T.; Phulippou H.; Lane D.A.; Hamulyak K.

The simpliRED D-Dimer test in diagnosis of pulmonary embolism. First results of a prospective study.
pp. 8-8(1)
Authors: Bonte A.; Wallis J.W.; den Heeten G.J.

The activation of factor XI by thrombin: from an explanation for the bleeding tendency in factor XI deficient patients to a new blood coagulation model.
pp. 8-8(1)
Authors: von dem Borne P.A.K.; Meijers J.C.M.; Bouma B.N.

Wegener's granulomatosis complicated by thrombo-embolism.
pp. 8-9(2)
Authors: Daal J.O.; op de Hoek C.T.

Clinical and laboratory parameters in APC-resistant and non-APC-resistant patients with deep venous thrombosis (DVT).
pp. 9-9(1)
Authors: van Hengel P.; Rondeel J.M.M.; Imambaks M.; Dinkelaar R.B.; van Vliet A.C.M.

Study on the interaction between omeprazole and acenocoumarol.
pp. 9-10(2)
Authors: de Hoon J.N.J.M.; Thijssen H.H.W.; Beysens A.J.M.M.; Van Bortel L.M.A.B.

Substantial impairment of hemostasis by the intravenous administration of a gelatin-based plasma expander.
pp. 10-10(1)
Authors: de Jonge E.; Levi M.; Berends F.; ten Cate J.W.; Stoutenbeek C.P.

Coagulation factor XI: rather a fibrinolytic inhibitor than a coagulation factor.
pp. 10-10(1)
Authors: Minnema M.C.; Levi M.; Meijers J.C.M.; Biemond B.J.; Bouma B.N.; ten Cate H.

Disseminated thrombosis, an unusual and catastrophic manifestation of the antiphospholipid syndrome.
pp. 10-11(2)
Authors: Schaar C.G.; Boets E.P.M.; Ronday H.K.; Breedveld F.C.

Assessment of prevention of venous thromboembolism in a university hospital.
pp. 11-11(1)
Authors: Verheul A.J.; Janssen M.C.H.; Boll B.; Wollersheim H.; Novakova I.; Thien T.

The use of novel laboratory tests for the hypercoagulable state in malignant disease.
pp. 11-12(2)
Authors: Waale W.H.E.; van Oerle R.; van Pampus L.; Hamulyak K.

Pulmonary embolism diagnosis with compression ultrasound and selective pulmonary angiography as only diagnostic tools. First results of a prospective study regarding clinical utility, reliability and safety.
pp. 12-12(1)
Authors: Wallis J.W.; den Heeten G.J.; van der Heul C.; Buller H.R.; ten Cate J.W.

Cell differentials in induced sputum after inhaled leukotriene D₄ in subjects with mild, persistent asthma.
pp. 12-13(2)
Authors: Diamant Z.; van Rensen E.L.J.; Callenbach P.M.C.; Veselic-Charvat M.A.; van der Veen H.; Sterk P.J.

The value of diagnostic features of pulmonary tuberculosis in a rural hospital in Zimbabwe.
pp. 13-13(1)
Authors: Buis S.; Mainberger M.; Stuiver P.C.; Hekking P.R.M.; Overbosch D.

Serial thoracentesis for the treatment of thoracic empyema.
pp. 13-13(1)
Authors: Simmers T.A.; Jie C.; Sie M.C.T.B.

Prognostic factors in hypoxic COPD. A ten year follow-up study in patients treated with oxygen at home.
pp. 13-14(2)
Authors: Lion H.L.; Slingerland R.; Heysteeg M.; Dees A.

Clinical experience with spiral CT angiography in the diagnosis of renal artery stenosis.
pp. 14-14(1)
Authors: van Ginneken E.E.M.; Jongen-Lavrencic M.; Bodewes H.W.; Teertstra H.J.; Hollander A.A.M.J.; Jansen J.L.J.; Koolen M.I.

Assessment of PMN degranulation during haemodialysis: granule products and cell surface markers.
pp. 14-14(1)
Authors: Grooteman M.P.C.; Bos J.C.; van Houte A.J.; Schoorl M.; Nube M.J.

In adequately treated hemodialysis patients, dialysis efficiency measured using either a urea monitor or the Daugirdas equation is not related to protein catabolic rate, protein intake, or serum albumin.
pp. 14-15(2)
Authors: Hasper H.J.; Brink H.S.; Brouwer R.M.L.

Analysis of ultrafiltration failure (UFF) in peritoneal dialysis patients.
pp. 15-15(1)
Authors: Ho-dac-Pannekeet M.M.; Atasever B.; Krediet R.T.

ACE gene polymorphism does not determine short-term renal response to ACE inhibition in proteinuric patients.
pp. 15-15(1)
Authors: van der Kleij F.G.H.; Navis G.J.; Scheffer H.; de Zeeuw D.; de Jong P.E.

Acidosis correction in hemodialysis (HD) patients influenced amino acid metabolism but had no major impact on body composition.
pp. 15-16(2)
Authors: Kooman J.P.; Deutz M.; Gerlag P.G.G.; van den Wall Bake A.; van Hooff J.P.; Leunissen K.M.L.

Characteristics of mannitol nephrotoxicity syndrome: review of 29 cases.
pp. 16-16(1)
Authors: vd Linden K.; van Hengel P.; Rondeel J.M.M.; van Bommel E.F.H.

Phosphate ingestion in vegetable versus animal food.
pp. 16-17(2)
Authors: de Meijer A.R.; Go L.H.; Dommerholt J.; Schuurmans M.

Evaluation of parameters for iron reserve in hemodialysis patients.
pp. 17-17(1)
Authors: Otte J.A.; Koning-Mulder W.A.H.; van der Sluijs Veer G.; Vermes I.; Jordans J.G.M.

The value of the Cockcroft formula in obese diabetic patients.
pp. 17-17(1)
Authors: van de Ree M.A.; van der Vijver J.C.M.; Geerlings W.

Improved dialysis efficacy during acetate free biofiltration.
pp. 17-18(2)
Authors: Schrander-v.d. Meer A.M.; ter Wee P.M.; Donker A.J.M.; v. Dorp W.T.

Assessment of adrenocortical function during prolonged stress activation in critical illness.
pp. 18-18(1)
Authors: Beishuizen A.; Gerritsen R.T.; Haanen C.; Vermes I.

Plasma clearance of intravenously injected vitamin A labeled triglyceride-rich particles in normolipidemic subjects.
pp. 18-18(1)
Authors: Castro Cabezas M.; van Beek A.; de Bruin T.W.A.; Erkelens D.W.

The prevalence and the course of neuromuscular dysfunction in hypo- and in hyperthyroidism.
pp. 18-19(2)
Authors: van den Bosch J.; Duyff R.F.; Linssen W.H.J.P.; Potter van Loon B.J.

Uncoupling of bone formation and bone resorption in women with hip fractures. A prospective study.
pp. 19-19(1)
Authors: van Daele P.L.A.; Birkenhager J.C.; Hofman A.; Pols H.A.P.

Limited joint mobility in patients with diabetes mellitus.
pp. 19-19(1)
Authors: Erdtsieck R.J.; van der Laan M.; Jacobs M.L.; Weber R.F.A.; Elte J.W.F.

Evaluation of diabetic footcare education.
pp. 19-20(2)
Authors: Goker E.; Hoff C.E.; Dooren J.; Bakker K.

The induction and recovery of the sick euthyroid syndrome after administration of recombinant human tumor necrosis factor in cancer patients.
pp. 20-20(1)
Authors: Feelders R.A.; Swaak A.J.G.; Romijn J.A.; Tielens E.T.; Eggermont A.M.M.; Vreugdenhil G.; Endert E.; van Eijk H.G.; Berghout A.

Pre-meal therapy with lispro insulin and regular insulin in IDDM patients.
pp. 20-21(2)
Authors: Holleman F.; Schmitt H.; Symanowski S.M.; Rees A.; Rottiers R.; Anderson J.H.

Short-term effects of ¹³¹I therapy on thyroid function in thyrotoxic patients receiving -blockade without antithyroid drugs.
pp. 21-21(1)
Authors: Koornstra J.J.; Kerstens M.N.; Hoving J.; Schade J.H.; Leemhuis M.P.

The influence of acute and chronic illness on thyroid weight.
pp. 21-21(1)
Authors: de Jongh F.E.; Jobsis A.C.; Elte J.W.F.

Change in body composition after growth hormone replacement therapy in growth-hormone-deficient adults, as assessed by bioelectrical impedance analysis.
pp. 21-22(2)
Authors: Koornstra J.J.; Jakobsdottir S.; Huisman J.; van Lijf J.H.; Lekkerkerker J.F.F.

Gliclazide entrances only second phase insulin release in long-standing NIDDM.
pp. 22-22(1)
Authors: Ligtenberg J.J.M.; Venker C.E.; Reitsma W.D.; Van Haeften T.W.

The effect of improved metabolic control on LDL susceptibility to oxidation in subjects with NIDDM.
pp. 22-22(1)
Authors: Oranje W.A.; Rondas G.J.W.M.; Swennen G.N.M.; Wolffenbuttel B.H.R.

Hypernatremia in the intensive care ward - a predictor of outcome and parameter of quality of care.
pp. 22-23(2)
Authors: Polderman K.H.; Schreuder W.O.; van Schijndel R.J.M.S.; Thijs L.G.

Calcium homeostasis in intensive care patients should be monitored by measurements of ionized calcium.
pp. 23-23(1)
Authors: Post A.T.; Janssen J.W.; Reitveld A.P.

Fasting and post-methionine homocysteine levels in patients with NIDDM.
pp. 23-23(1)
Authors: Rakie M.; Smulders Y.M.; Treskes M.; Slaats E.H.; Stehouwer C.D.A.; Silberbusch J.

Computerized inventory of the outward clinic diabetic patient population.
pp. 24-24(1)
Authors: van de Ree M.A.; Wernink W.P.; Bijloo C.; van der Vijver J.C.M.

Cytokine production by mononuclear cells of patients with familial hypercholesterolemia.
pp. 24-24(1)
Authors: Rovers C.P.; Netea M.G.; Demacker P.N.M.; Boerman O.C.; Jacobs C.; Kullberg B.J.; van der Meer J.W.M.; Stalenhoef A.F.H.

Nocturnal hypoglycaemia in type 2 diabetic patients on multiple (=< 4) daily insulin injections.
pp. 24-24(1)
Authors: Schoon Y.; van Doorn L.G.

Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus.
pp. 25-25(1)
Authors: Smulders Y.M.; Rakic M.; Slaats E.H.; Treskes M.; Stehouwer C.D.A.; Silberbusch J.

Presence of 11- hydroxysteroid dehydrogenase type 2 activity in human forearm.
pp. 25-25(1)
Authors: van Uum S.H.M.; Hermus A.R.M.M.; Smits P.; Swinkels L.M.J.W.; Thien T.; Lenders J.W.M.

Shared care for NIDDM patients in general practice: sustained good glycaemic control after 2 years.
pp. 25-25(1)
Authors: de Sonnaville J.J.J.; Bouma M.; Colly L.P.; Wijkel D.; Heine R.J.

The plasma aldosterone/plasma renin activity ratio at different salt intakes has a limited value for the diagnosis of primary aldosteronism.
pp. 25-26(2)
Authors: van Uum S.H.M.; van Maurik E.; Hermus A.; Swinkels L.M.J.W.; Thien T.; Lenders J.W.M.

Hyperfiltration in non-complicated IDDM is not related to metabolic control, blood pressure or plasma volume.
pp. 26-26(1)
Authors: Vervoort G.; Wetzels J.; Lutterman J.; Berden J.; Smits P.

Urapidil and doxazosine do not differ with regard to the acute cardiovascular autonomic effects in patients with essential hypertension.
pp. 26-27(2)
Authors: Bijlstra P.; Lenders J.W.M.; Kleinjans H.A.J.; Thien T.

Vasculitis as the first presentation of an atrial myxoma.
pp. 27-27(1)
Authors: Bonapart I.E.; Baggen M.G.A.

The sustained effect of once-daily enalapril versus lisinopril: calculation of trough-to-peak ratio from 24-h ambulatory blood pressure measurements by Fourier analysis.
pp. 27-27(1)
Authors: Vincent H.H.; Diamant M.

Endothelin and active renin levels before and after ACE inhibition in patients with successful and unsuccessful blood pressure responses to PTRA treatment of renal artery stenosis.
pp. 27-28(2)
Authors: Teunissen K.E.; Postma C.T.; van Jaarsveld B.C.; Derkx F.H.M.; Thien T.

Response in red cell deformability to a daily intake of red wine or a wine capsule for 2 weeks in healthy male volunteers.
pp. 28-28(1)
Authors: van Golde P.H.M.; Hardeman M.R.; Kraaijenhagen R.J.; Hart H.C.; Bouma B.N.; van de Wiel A.

Improvement in cerebral blood flow velocity in a patient with postural tachycardia syndrome after prolonged bedrest
pp. 28-28(1)
Authors: Harms M.P.M.; Wieling W.; van Lieshout J.J.

Aggregation of platelets is inhibited in vitro by red wine as well as its alcohol-deprived equivalent: ethanol is not a necessary component
pp. 28-29(2)
Authors: van Golde P.H.M.; Hart H.C.; van der Meijden B.B.; Kraaijenhagen R.J.; Bouma B.N.; van de Wiel A.

Non-invasive continuous cardiac output measurement by Modelflow during orthostatic stress in humans
pp. 29-29(1)
Authors: Harms M.P.M.; van Lieshout J.J.; van Goudoever J.; Settels J.J.; Jenstrup M.; Pott F.; Secher N.H.; Wesseling K.H.

Hypertension and quality of life: bisoprolol versus nifedipine retard
pp. 29-29(1)
Authors: de Hoon J.N.J.M.; Vanmolkot F.H.M.; van de Ven L.L.M.; Van Bortel L.M.A.B.

Clinical and haemodynamic sequelae of venous thrombosis: retrospective evaluation after 7 to 13 years
pp. 29-30(2)
Authors: Janssen M.C.H.; Haenen J.H.; van Asten W.N.J.C.; Wollersheim H.; Heijstraten F.M.J.; de Rooij M.J.M.; Thien T.

Idiopathic marked elevation of angiotensin converting enzyme activity in humans is not related to high blood pressure or cardiovascular disorders.
pp. 30-30(1)
Authors: Kramers C.; Boomsma F.; Lenders J.W.M.; de Keijzer M.; Sweep C.; Smits P.

Sodium sensitivity of blood pressure during sodium restriction is related to inadequate activation of renin during the early phase of sodium loss
pp. 30-30(1)
Authors: Krekels M.M.E.; Schaper N.C.; De Leeuw P.W.

The effect of arginine-vasopressin on endothelin production in the human forearm.
pp. 31-31(1)
Authors: Maessen S.M.J.; Postma C.T.; Thien T.; Smits P.

Comparison of multiple-dose and once-daily nitrate therapy in patients with stable angina pectoris: effects on quality of life indices.
pp. 31-31(1)
Authors: Dutch Mononitrate Quality of Life Study Group; v. Ooteghem R.B.C.; Niemeyer M.G.; Zwinderman A.H.; Cleophas T.J.M.; v.d. Meulen J.; Kofflard R.

Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide.
pp. 31-32(2)
Authors: Peters F.P.J.; Braat S.H.; Heymeriks J.; Wellens H.J.J.

Direct vascular effects of acetazolamide in man.
pp. 32-32(1)
Authors: Pickkers P.; Russel F.G.M.; Thien T.; Smits P.

Modulation of plasma endothelin levels by the menstrual cycle.
pp. 32-32(1)
Authors: Polderman K.H.; Stehouwer C.D.A.; Gooren L.J.G.

A selective screening program for hereditary dyslipidemia and treatment in a lipid research clinic setting.
pp. 32-32(1)
Authors: van de Ree M.A.; Lansberg P.J.; Kastelein J.J.P.; Ten Cate J.W.

Intima-media thickness of the common carotid artery measured by 2 different echo techniques.
pp. 32-33(2)
Authors: Spek J.J.; Vanmolkot F.; Staessen J.A.; Van Bortel L.M.A.B.

Mechanism of the antihypertensive effect of losartan.
pp. 33-33(1)
Authors: Roeloffzen W.W.H.; Woittiez A.J.J.

The effects of age on large artery wall properties differ between men and women.
pp. 33-33(1)
Authors: Spek J.J.; Staessen J.A.; Hoeks A.P.G.; Boudier H.A.J.S.; Van Bortel L.M.A.B.

Epilepsy as presenting symptom of coeliac disease.
pp. 33-34(2)
Authors: de Bruyne E.L.E.; Willems M.H.A.; Baggen M.G.A.; Ouwendijk R.J.T.

Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
pp. 34-34(1)
Authors: Roozendaal C.; Jagt T.G.; Pogany K.; Horst G.; Kleibeuker J.H.; Nelis G.F.; Limburg P.C.; Kallenberg C.G.M.

Food impaction of a duodenal diverticulum as an unusual cause of biliary obstruction.
pp. 34-34(1)
Authors: van der Linde K.; van der Linden G.H.M.; Beukers R.; Cleophas A.J.M.

Low-dose oral cyclosporin treatment in steroid-refractory ulcerative colitis: clinical outcome and cyclosporin blood concentrations.
pp. 34-35(2)
Authors: Linskens R.K.; Van Bodegraven A.A.; Van Haelst I.M.M.; Tuynman H.A.R.E.; Sindram J.W.

Oesophageal segmental acid sensitivity in patients with endoscopy-negative GORD.
pp. 35-35(1)
Authors: Niemantsverdriet E.C.; Timmer R.; Breumelhof R.; Smout A.J.P.M.

Salmonellosis: an unusual manifestation of carcinoma metastatic to the liver.
pp. 35-35(1)
Authors: Mijnhout S.; Simmers T.A.; Van Meyel J.J.M.

Vitamin D deficiency and osteopenia in Crohn's disease.
pp. 35-36(2)
Authors: van Nunen A.B.; Schoon E.J.; Russell M.G.; Stockbrugger R.W.; Brummer R.-J.

Fatal pericarditis with Candida albicans as a result of esophageal neoplasia.
pp. 36-36(1)
Authors: Pogany K.; Brugemann J.; Kleibeuker J.H.

Enhanced mucosal fibrinolytic activity in patients with bleeding gastro-duodenal ulcers: beneficial effect of acid suppression.
pp. 36-36(1)
Authors: Vreeburg E.M.; Levi M.; Rauws E.A.J.; van Deventer S.J.H.; Snel P.; Bartelsman J.W.F.M.; ten Cate J.W.; Tytgat G.N.J.

TPN in critically ill patients: the influence on bile secretion.
pp. 36-37(2)
Authors: de Vree J.M.L.; Mathus-Vliegen E.M.H.; Ostrow J.D.; Sauerwein H.P.; Stoutenbeek C.P.; Tytgat G.N.J.; Elferink R.P.J.O.; Groen A.K.; Romijn J.A.

Disseminated strongloidiasis in 2 patients treated with immunosuppressive drugs.
pp. 37-37(1)
Authors: van der Beek A.; Buurke E.J.

Viral load in HIV seropositive patients treated with antiretroviral triple-therapy.
pp. 37-38(2)
Authors: Blans M.J.; van der Heul C.; Santegoeds R.; van der Ven B.; Buiting A.; Cuypers H.T.M.; Juttmann J.R.

Dexamethasone, but not chlorpromazine, decreases exvivo tumor necrosis factor- and interleukin-1 production in human volunteers.
pp. 38-38(1)
Authors: Bleeker M.W.P.; Netea M.G.; Kullberg B.J.; van der Meer J.W.M.

The effect of infection control compliance, prevalence of colonization, and other risk factors on spread of vancomycinresistant enterococci (VRE).
pp. 38-38(1)
Authors: Bonten M.; Slauhter S.; Hayden M.; Nathan C.; Weinstein R.A.

Defective bactericidal capacity of monocytes from a patient with malakoplakia.
pp. 38-38(1)
Authors: van Crevel R.; Curfs J.; van der Ven A.J.A.M.; van der Meer J.W.M.

Prognostic significance of reduced red cell deformability in severe falciparum malaria.
pp. 39-39(1)
Authors: Dondorp A.M.; Kager P.A.; White N.J.; Vreeken J.

The occurrence of Gram-negative bacilli other than Escherichia coli in the bowel flora of patients in a psychogeriatric nursing home.
pp. 39-39(1)
Authors: van Kemenade J.; de Meijer A.R.; Vollaard E.J.

Opiate analgesia modulates the inflammatory, endocrine and metabolic responses to endotoxin in dogs.
pp. 39-39(1)
Authors: Moeniralam H.S.; Endert E.; van Lanschot J.J.B.; Sauerwein H.P.; Romijn J.A.

Aortic graft infection by Lactobacillus casei.
pp. 39-40(2)
Authors: Schoon Y.; Schuurman B.; Kranendonk S.E.; Buiting A.; Graafsma S.J.

Erythromycin suppresses the synthesis of cytokines in whole blood stimulated with heat-killed Streptococcus pneumoniae.
pp. 40-40(1)
Authors: Schultz M.J.; Speelman P.; van Deventer S.J.H.; van der Poll T.

Type 2 immune response phenomena in patients infected with HIV.
pp. 40-40(1)
Authors: Spronk P.E.; Bergkamp F.; ten Kate R.W.

Attitude of elderly in-patients towards discussing cardiopulmonary resuscitation.
pp. 40-41(2)
Authors: Schuur J.; van Dijk D.M.; Capel A.A.; van Loon B.J.P.

Increased concentrations of circulating cytokine receptors and increased ex-vivo production of IL-1ra and IL-1 but decreased TNF production after a short exercise run.
pp. 41-41(1)
Authors: Drenth J.P.H.; Krebbers R.; Bijzet J.; van der Meer J.W.M.

Acute folate deficiency following high volume continuous venovenous hemofiltration.
pp. 41-41(1)
Authors: Geerlings S.E.; Rommes J.H.; van Toorn D.W.; Bakker J.

Evaluation of new parameters for iron reserve in healthy volunteers.
pp. 41-42(2)
Authors: Otte J.A.; Koning-Mulder W.A.H.; van der Sluijs Veer G.; Vermes I.; Jordans J.G.M.

Carotid artery wall thickness and cardiovascular risk factors.
pp. 42-42(1)
Authors: Smilde T.J.; Wollersheim H.; Boers G.H.J.; Stalenhoef A.F.H.

Author Index - Abstracts - Only first authors are listed; numbers are those of the Abstracts
pp. 43-44(2)

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis
pp. 191-197(7)
Author: DeFronzo R.A.

Osteoporosis: a view into the next century
pp. 198-203(6)
Author: Kanis J.A.

The internist and the vessel wall
pp. 204-210(7)
Author: Luscher T.F.

Cancer and genes: how will molecular biology reshape our clinical practice?
pp. 211-215(5)
Author: Ponder B.A.J.

Emerging infections and newly-recognised pathogens
pp. 216-220(5)
Author: Relman D.A.

Tomorrow's world: atherosclerosis in the year 2000
pp. 221-227(7)
Author: Shepherd J.

Gastro-entero-hepatology in the next millennium
pp. 228-232(5)
Author: Tytgat G.N.J.